GILD Stock Up 8% Now, Gilead Sciences Coronavirus Drug Remdesivir Reports Rapid Recovery

Gilead Sciences (GILD) stock is climbing on news of that its coronavirus Remdesivir proved to be efficient even in severe cases. The stock could rise much further as trials continue.